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Abstract: Assisted dying practices, which include euthanasia and physician-assisted suicide (PAS), have 
expanded significantly around the world over the past 20 years. Euthanasia refers to the act of intentionally 
ending the life of a patient by a health care practitioner through medical means at that patient’s explicit 
request while PAS involves the provision or prescribing of drugs by a health care practitioner for a patient to 
end their own life. The growing global aging population accompanied by higher levels of chronic disease and 
protracted illnesses have sharpened the focus on end of life issues and societal and legislative debates continue 
to address related moral and ethical complexities. Assisted dying practices are now legal in 18 jurisdictions, 
increasing the number of people with access to euthanasia and/or physician-assisted suicide (PAS) to over 
200 million. New legislation is being crafted or considered in Portugal, Spain and 16 US states. Germany 
has recently overturned a ban on assisted dying services and New Zealand will put legalization of euthanasia 
to a vote in 2020. Assisted dying practice characteristics differ and there is also considerable variation in the 
terminology and labels used for assisted dying, which can add to the confusion and controversy around the 
practices. Frequency of use also varies greatly by jurisdiction, though a consistent increase has been seen in 
European countries including Belgium, the Netherlands and Switzerland as well as some jurisdictions with 
long-standing physician assisted dying laws, such as Oregon and Washington. All assisted dying legislation 
includes substantive and procedural requirements, such as minimum age, waiting period, health condition, 
physician consultation and reporting procedure, however, some are extensive and detailed while others are 
more limited. As access to assisted dying expands in new and existing jurisdictions, research must also expand 
to diligently examine the impact on patients, specifically among vulnerable populations, as well as on health 
care practitioners, health care systems and communities. This article will provide a thorough investigation, 
or ‘status quaestionis’ of the terminology, evolution and current legislative picture of assisted dying practices 
around the globe and contribute to the ongoing ethical, regulatory and practice debate, which have become 
increasingly important considerations for medical practice, end-of-life care and public health.
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Introduction
In developed nations, chronic conditions such as cancer 
and cardiovascular disease are leading causes of death. 
These conditions are sometimes associated with long and 
debilitating trajectories complicated by the use of medical-
technological interventions, which can extend life but can 
also lead to protracted suffering (1,2). Disease-associated 
pain, suffering, functional and cognitive decline and 
associated experiences of loss of dignity and autonomy 
motivate some people to wish for hastened death (1,3). 
Increasing public discourse around patient autonomy, 
quality of life and what constitutes a ‘good death’ is also 
impacting perceptions and support for assisted dying 
legislation in a growing number of countries. 
Assisted dying practices, which include euthanasia and 
PAS, have become increasingly important considerations 
for medical practice, end-of-life care and public health (3,4). 
Euthanasia refers to the act of intentionally ending the 
life of a patient by a health care practitioner by means of 
active drug administration at that patient’s explicit request. 
PAS is similar to euthanasia but involves the provision or 
prescribing of drugs by a health care practitioner for a 
patient to use to end their own life (5). The term “assisted 
dying” is used in this article as an umbrella term referring 
to both the practice of euthanasia and PAS.  This article 
will provide an overview of the terminology, evolution and 
current legislative picture of assisted dying practices around 
the globe. 
Labelling and definitions vary by jurisdiction or 
country
The modern meaning of the term euthanasia began 
in the 20th century with the growth of the right-to-die 
organizations and voluntary euthanasia organizations who 
supported legalization of the practice (5). The debate 
around euthanasia was reinvigorated in 1973 by a legal case 
in the Netherlands involving a physician who used a lethal 
injection to end the life of her dying mother at her mother’s 
request (6). The physician’s light sentencing led to increased 
legal deliberation and tolerance in the Netherlands, where 
eventually euthanasia was legalized in 2002 (6). 
The term “passive euthanasia” was often previously 
used to refer to passive decisions, including withholding or 
withdrawing life-sustaining or life-prolonging treatment, 
however this use leads to confusion and is not accurate given 
that ‘euthanasia’ is legally defined as active and voluntary in 
countries with such legislation (5). In the US and elsewhere, 
termination of potentially life sustaining treatments is 
considered ethical and legal when carried out with the 
patient or proxy’s agreement (7). Referring to acts that are 
outside a patient’s request as “non-voluntary euthanasia” 
or “involuntary euthanasia”, are likewise unsuitable as 
these terms refer to the act of administering lethal drugs 
without the patient’s explicit request, which falls outside the 
definition of euthanasia (5). In most European countries, 
cases involving involuntary and nonvoluntary death are 
referred to as “termination of life without the patient’s 
explicit request” (7). 
The labelling and legal definitions of euthanasia or PAS 
vary by country and are debated (7). Various terms are used 
to refer to assisted dying practices including: euthanasia, 
PAS, medically assisted suicide, physician-assisted dying, 
voluntary assisted dying (VAD), physician aid in dying and 
medical aid in dying (7,8). The meaning and use of these 
terms are not consistent or universally agreed upon, which 
results in ongoing confusion and adds to the controversy 
surrounding them (9,10). The term physician-assisted 
dying is frequently used, particularly in Europe (7). There 
is ongoing debate in the United States about which term 
is most appropriate to refer to assisted dying. The term 
PAS has been commonly used, however, there has been a 
shift toward use of medical aid in dying and it is seen more 
frequently in scientific literature and legislation, along with 
the term death with dignity (8,11). Medical-aid-in dying 
(MAiD) is used to refer to both the practices of euthanasia 
and assisted suicide and is commonly used in Canada, where 
both a physician and nurse practitioner are allowed to 
perform the practices (5,12). In Australia, the term VAD is 
used for the practice of physician-assisted dying, and the law 
prioritizes PAS above euthanasia. Health care practitioners 
can only use euthanasia when the patient has a medical 
condition that excludes PAS, for example, when the patient 
can no longer swallow.
The variation and confusion associated with assisted 
dying terminology is likely influenced and compounded by a 
range of factors including the use of qualifiers, such as active 
and passive when speaking about euthanasia, the desire to 
avoid terms like euthanasia and suicide based on concerns 
that they are morally or emotionally loaded or inaccurate, 
and overlapping or ambiguous terms such as medical 
assistance in dying, which could be used to reference both 
PAS and euthanasia (8,9,13). Research has indicated that 
public attitudes on assisted dying are embedded in cultural, 
religious and spiritual traditions and historical experience, 
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which also likely impacts the terminology used to reference 
these practices within the socio-cultural context in various 
jurisdictions (13).  
Background and current legal status worldwide
Euthanasia is currently legal in seven jurisdictions: the 
Netherlands (since 2002), Belgium (since 2002), Luxemburg 
(since 2009), Colombia (since 2015), Canada (since 2016) 
and Victoria (since 2017) and Western Australia (since 2019) 
in Australia (Table 1). Western Australia passed euthanasia 
legislation as of December 2019 with an 18-month 
implementation phase before the law comes into effect in 
mid-2021 (14). As of February 2020, the Spanish legislature 
is debating a bill that would legalize euthanasia and assisted 
suicide and similar legislation is being crafted in Portugal 
following the approval of related proposals by parliament 
(15,16). New Zealand’s parliament voted in favor of 
legalizing euthanasia in late 2019 and a national referendum 
on the issue will take place in September 2020 (17).
The Northern Territory in Australia was the first 
jurisdiction to legalize euthanasia in 1995, however, the 
law was overturned after just nine months by the federal 
Parliament of Australia (5). Prior to legalization in the 
Netherlands, there was a period of legal tolerance of 
euthanasia between the mid-1980s and 2001, provided that 
specific practice requirements were fulfilled as outlined 
by the Royal Dutch Medical Association (5). Both the 
Netherlands and Belgium legalized euthanasia in 2002, and 
Luxembourg followed in 2009 (7). Colombia is the only 
country in Latin America that permits assisted dying and 
it is the only jurisdiction that requires the approval of an 
independent committee prior to euthanasia being performed 
(7,18). Although the Colombian Constitutional Court 
decriminalized “mercy homicide” in 1997, process rules 
were not put into place until 2015 (18). The legalization 
of euthanasia in Canada came as a result of the Supreme 
Court case Carter vs. Canada and provinces were required 
to draft laws legalizing euthanasia by February 2016, which 
was later delayed to June 2016. In the Australian state of 
Victoria, euthanasia and assisted suicide are allowed by law 
via the Voluntary Assisted Dying Bill of 2017, effective as of 
June 2019 (5). 
PAS without the option for euthanasia, is legally 
practiced in Switzerland and ten US jurisdictions. In 1942, 
Switzerland indicated in its penal code that assisting in a 
suicide is not considered a crime as long as there are no 
covetous motivations, such as seeking to gain inheritance (7). 
Since the 1980s, right-to-die organizations have been 
interpreting the law as legal permission to operate 
organizations to support people who wish to obtain assisted 
suicide, including nonresidents (7). In 2006, the Federal 
Court of Switzerland extended the law to include those with 
mental disorders and imposed standardized process rules 
requiring increased documentation and reporting from the 
organizations that provide assisted suicide (19). After efforts 
to legalize euthanasia in the United States in the early 
1900s failed, it wasn’t until the 1980s and the promotion of 
pathologist, Dr. Jacob “Jack” Kevorkian that the national 
conversation was renewed (8). Fierce public debate led 
to several court cases and eventually the US Supreme 
Court ruled that right-to-die decisions would be left to the 
states (8). Since 1997, PAS has been legalized in nine 
US states and one district: Oregon (Death with Dignity 
Act; 1997), Washington (Death with Dignity Act; 2009), 
Montana (by Supreme Court ruling; 2009), Vermont 
(Patient Choice and Control at the End of Life Act; 2013), 
California (End of Life Option Act; 2016), Colorado (End 
of Life Options Act; 2016), District of Columbia (D.C. 
Death with Dignity Act; 2017), Hawaii (Our Care, Our 
Choice Act; 2019), Maine (Death with Dignity Act; 2019), 
New Jersey (Aid in Dying for the Terminally Ill Act; 2019). 
Sixteen other states are considering death with dignity 
laws in 2020, or the current legislative session, including: 
Utah, Arizona, Minnesota, Iowa, Wisconsin, Indiana, 
Kentucky, Georgia, Florida, Virginia, Maryland, New 
York, Connecticut, Rhode Island, Massachusetts, New 
Hampshire (11). In February 2020, the German supreme 
court overturned a law banning the provision of assisted 
suicide services, which includes prescribing lethal doses 
of sedatives to terminally ill patients and providing 
consultation on how to legally access life-ending assistance 
in other countries (20).
Legal requirements and safeguards
Every jurisdiction that has legalized euthanasia and/or 
physician-assisted suicide has implemented substantive and 
procedural requirements and safeguards (5) (Table 2). Most 
jurisdictions impose minimum age restrictions for euthanasia 
and physician-assisted suicide to be permissible (7). 
In Canada, Luxembourg and the United States, a person 
must be at least 18 years old to request physician-assisted 
suicide (7). In the Netherlands, a patient can request 
assisted dying from the age of 12 years old (7). Belgium 
has allowed a patient of any age to request euthanasia or 
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Table 2 Assisted dying legal requirements and safeguards
Jurisdiction Euthanasia PAS
Age 
requirement
Diagnosis/prognosis 
required
Waiting period 
required
Peer 
consultation 
required
Commmittee 
review
Europe
Switzerland No Yes None 
specified
None specified None specified None specified None specified
The Netherlands Yes Yes 12 None specified None specified Yes Yes 
Belgium Yes Not legal 
(but 
condoned)
None 
specified
Adults: incurable 
condition; Minors: 
terminal
None, terminal 
1 month, non 
terminal
Yes Yes
Luxembourg Yes Yes 18 Incurable condition None specified Yes Yes
America
Canada Yes Yes 18 Grievous and 
irremediable 
medical condition
10 days written 
request
Yes No
Quebec Yes No 18 Serious, incurable 
illness
10 days written 
request
Yes No
Colombia Yes Yes 18 Terminal Within 15 days 
after committee 
approval
Committee 
approval 
required
Yes, before 
euthanasia or 
PAS performed
USA
Oregon No Yes 18 Terminal, <6 months 15 days oral 
request, 48 hours 
written request
Yes None specified
Washington No Yes 18 Terminal, <6 months 15 days oral 
request, 48 hours 
written request
Yes None specified
Montana No Yes None 
specified
None specified None specified Not specified None specified
Vermont No Yes 18 Terminal, <6 months 15 days oral 
request, 48 hours 
written request
Yes None specified
California No Yes 18 Terminal, <6 months 15 days oral 
request
Yes None specified
Colorado No Yes 18 Terminal, <6 months 15 days oral 
request
Yes None specified
District of 
Columbia
No Yes 18 Terminal, <6 months 15 days oral 
request, 48 hours 
written request
Yes None specified
Hawaii No Yes 18 Terminal, <6 months 20 days oral 
request, 48 hours 
written request
Yes None specified
Maine No Yes 18 Terminal, <6 months 17 days oral 
request, 48 hours 
written request
Yes None specified
Table 2 (continued)
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physician-assisted suicide since 2014, provided they are of 
mature judgement (7). Switzerland does not specify an age 
at which a person can request assisted suicide though most 
right-to-die organizations require the person to be an adult 
with sound judgement (21). 
While assisted dying legislation in the Netherlands 
and Belgium are functionally similar and the prescribed 
safeguards are limited in number, other jurisdictions like 
Western Australia have extensive detailed requirements 
related to access, eligibility (for those making requests and 
the practitioners handling requests), notification, referral, 
assessment, documentation and reporting. The level of 
specificity included in the legislation goes well beyond that 
of the law passed in 2017 in the Australian state of Victoria, 
which was already fairly extensive. Legislation for MAiD 
in Canada is similarly succinct to the European laws and 
does not include a diagnosis requirement but does require 
a waiting period of 10 days, unlike laws in the Netherlands, 
Belgium and Luxembourg. Variation among assisted dying 
laws has significant implications for patients, physicians 
and health care systems relative to access, care delivery and 
reporting. It is also an important consideration impacting 
cross-national comparison of assisted dying practice and 
incidence. Although variability exists, there are some 
similarities in the substantive and procedural safeguards 
between jurisdictions (5,7). 
Commonalities among substantive requirements for 
assisted suicide and euthanasia include:
	The request must be voluntary, thoroughly considered 
and sustained/repeated over time;
	The person must have a serious and incurable 
condition caused by an illness or an accident (in the 
US, Colombia, and Victoria the person must also be 
expected to die imminently); 
	The person must have unbearable physical or 
psychological suffering which cannot be alleviated 
(not required for PAS in the US);
	The physician must inform the person about their 
condition and medical options and both parties must 
have reached the understanding that no reasonable 
likelihood of improvement exists.
Commonalities among procedural requirements for 
assisted suicide and euthanasia include:
	A second independent physician must by consulted 
by the treating physician before euthanasia is 
performed (a third consultation is required for non-
terminal cases in Belgium);
	The US and Canada require mandatory waiting 
periods between request and provision of assisted 
death; 
	Euthanasia must be reported by the physician 
following the procedure for review by a multidisciplinary 
control and evaluation committee (in Colombia this 
must be done prior to euthanasia being carried out)
Table 2 (continued)
Jurisdiction Euthanasia PAS
Age 
requirement
Diagnosis/prognosis 
required
Waiting period 
required
Peer 
consultation 
required
Commmittee 
review
New Jersey No Yes 18 Terminal, <6 months 18 days oral 
request, 48 hours 
written request
Yes None specified
Australia
Victoria Yes Yes 18 Terminal, <6 months 
(or 12 months for 
neurodegenerative 
conditions)
9 days written Yes Yes
Western 
Australia
Yes Yes 18 Terminal, <6 months 
(or 12 months for 
neurodegenerative 
conditions)
9 days written Yes Yes
PAS, physician-assisted suicide.
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What do we know to date about assisted dying 
practice?
Assisted dying practices and their consequences have been 
investigated for nearly thirty years (7). While euthanasia 
and physician-assisted suicide remain controversial and 
societal and legislative debates continue, over 200 million 
people around the world are now living in jurisdictions 
allowing some form of assisted dying (Figure 1) and many 
more states and countries are considering legalization (2,7). 
While practice characteristics vary by jurisdiction and 
existing laws require close monitoring, those without laws 
can benefit from the experiences of others to fuel societal 
debate and research data continues to be imperative.
Motivation for requests and patient demographics  
Studies indicate that pain is not typically the primary 
motivation for requesting euthanasia or physician-assisted 
suicide; inadequate pain control is seen in less than 33% of 
patients (7). Loss of autonomy, diminished quality of life 
and loss of dignity are the factors most frequently associated 
with requests for assisted dying (22). Loss of dignity is 
identified as the basis for requests in 61% of cases in the 
Netherlands and 52% in Belgium (7). Patients who request 
euthanasia or assisted suicide are most often dying of cancer 
(60–100% cases), though a lower percentage was seen in 
Switzerland (38–47%) (1). Other conditions associated 
with requests include amyotrophic lateral sclerosis 
(ALS), multiple sclerosis, cardiovascular disease and 
immunodeficiency syndrome (1). Although there is some 
variation by country, research indicates that the typical 
patient receiving euthanasia or physician-assisted suicide is 
white, highly educated and male, between 60 and 85 years 
old (1,7). In countries where both euthanasia and physician-
assisted suicide are legal options, euthanasia is far more 
frequently requested (21,23). One study in the Netherlands 
indicated that in 75% of cases, euthanasia was preferred (24). 
Frequency of assisted dying practices 
Information about the frequency of euthanasia and assisted 
death is obtained through mandatory reporting, which is 
part of the procedural requirement of the law (7) (Table 3). 
Mortality follow-back studies among attending physicians 
Figure 1 World population under assisted dying law.
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using a random sample of death certificates were developed 
in the Netherlands and have also been used to investigate 
the prevalence and characteristics of euthanasia and 
physician-assisted suicide in other countries (25). According 
to governmentally reported data, in the first years following 
legalization in the Netherlands in 2002, the number of 
euthanasia cases became steady at just under 2,000 cases 
per year (26). A gradual increase starting in 2007 saw 
the number climb to 6,585 cases in 2017, 4.38% of total 
deaths (26). The 2015 rate according to the Dutch mortality 
follow-back survey was 4.6% (27). 
The Belgian federal reporting data shows 2,655 cases 
reported in 2019 (est. 2.4%), which is an increase from 
2,357 cases recorded in 2018, 2.1% of all deaths (28). 
However, the reported use of euthanasia among Dutch-
speaking Belgians accounted for the majority of cases (76%), 
with far fewer cases reported among French-speaking 
Belgians (24%) (28). The follow-back survey in the Flanders 
region of Belgium, which includes a broader definition of 
euthanasia than the federal reporting system, found the 
frequency of euthanasia and assisted suicide was estimated 
at 4.6% of all deaths in 2013 (3,4). 
It is important to note that research in Belgium and 
the Netherlands has shown that not all cases of euthanasia 
Table 3 Jurisdictions with assisted death and frequency of reported euthanasia and assisted suicide
Jurisdiction Euthanasia and/or PAS?
Year of latest known 
number of deaths
Number of deaths by 
euthanasia and/or PAS
Percentage of  
all deaths
Europe
Switzerland PAS 2015 965 1.4%
Netherlands Euth and PAS 2018 6126 4.0%
Belgium Euth (PAS condoned) 2018 2357 2.1%
Luxembourg Euth and PAS 2018 8 a
America
Canada Euth and PAS 2018 2614(b) 1.1%
Colombia Euth and PAS a a a
USA
Oregon PAS 2018 168 0.5%
Washington PAS 2018 203 a
Montana PAS a a a
Vermont PAS a a a
California PAS 2018 337 0.1%
Colorado PAS 2018 86 a
District of Columbia PAS a a a
Hawaii PAS 2019 14 a
Maine PAS a a a
New Jersey PAS a a a
Australia
Northern Territory Euth and PAS 1996–1997 7 a
Victoria Euth and PAS a a a
Western Australia Euth and PAS a a a
a, data not (yet) available; b, number of medically assisted deaths in Canada provided between Jan 1 and Oct 31, 2018 (not including 
Quebec, NWT, YK, and NU). PAS, physician-assisted suicide.
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and assisted death are reported so these figures are likely 
underestimations of the actual extent of the practices (7). 
Some physicians who administer opiates with the intention 
of ending a person’s life at their request do not recognize 
their actions as euthanasia, and in other cases physicians 
do not want to follow the prescribed procedures using 
recommended medication because their patient does not 
satisfy all the required conditions or because they find the 
procedure overly cumbersome (29).  
Luxembourg had 11 cases of euthanasia in 2017, which 
was 0.26% of all deaths (30). In Canada, euthanasia deaths 
accounted for about 1.12% of all deaths between January-
October, 2018 (12). In Switzerland, there has been a 
consistent increase in cases of assisted suicide among Swiss 
residents and residents from other countries (primarily 
Germany) since 2000 (19). Approximately 150–200 people 
from other countries travel to Switzerland every year 
to access physician-assisted suicide, a practice known as 
“suicide tourism” (31). The annual number of cases of 
assisted suicide in Swiss residents nearly doubled from 
500 cases in 2012, to nearly 1,000 cases in 2016, equalling 
about 1.5% of all deaths (19). The mortality follow-back 
survey conducted in 2013 found that 1.0% of all deaths 
were attributed to assisted suicide in the German-speaking 
part of Switzerland (21).  
In the US state of Oregon, which has had the longest 
period of legalized physician-assisted suicide, from 1998 
to June 2017, 1,857 people received prescriptions for life-
ending medications, and 1,179 (64%) died from ingesting 
them (32). Data from Oregon during the years 1998–2015, 
combined with seven years of records from Washington 
[2009–2015] indicate that physician-assisted suicide 
accounted for less than 0.4% of all deaths, and nearly all 
years saw an increase in requests (7). In Oregon, the actual 
rate of deaths by request has fluctuated between 47.7% and 
81.8% (7).
Drugs used for euthanasia and assisted suicide 
Although physicians can use multiple types of drugs to 
perform euthanasia and some existing legislation specifies 
the use of particular drugs, those most often recommended 
within legal jurisdictions typically include a combination of 
(optional) benzodiazepine to relax the patient, followed by a 
high dose of a barbiturate such as thiobarbital, pentobarbital 
or secobarbital, which typically causes death, followed by a 
muscle relaxant, if required (5,11,33). The clinician is often 
not present when the patient administers the life-ending 
drugs in the US, usually by swallowing a lethal cocktail, 
however, in Belgium, the Netherlands and Luxembourg, 
physician presence is mandatory (5). The Dutch Medical 
Association has published guidelines on recommended and 
non-recommended drugs making it part of the professional 
conduct rules (29). In Belgium, pharmacists have published 
guidance on specific products and dosages and best practice 
information has been disseminated by the Life End 
Information Forum (LEIF) in Flanders, the Dutch-speaking 
part of Belgium (29). The drugs most commonly used 
for physician-assisted suicide include a self-administered 
barbiturate to induce unconsciousness after which death 
results slowly from asphyxia due to cardiorespiratory 
depression (34).
The (continued) debate around euthanasia and 
physician-assisted suicide
The ethical debates related to assistance in dying are 
complex and persistent. Supporters contend that the 
practices preserve an individual’s autonomy and self-
determination during the end of life and allow people to 
choose a death with dignity (5). Proponents also hold that 
euthanasia and assisted suicide are occasionally the only 
option to relieve unbearable suffering and that quality of 
life takes precedence over quantity of life (5). Advocates 
cite assisted dying as an important option in the care for 
those who are dying, one in which physicians can facilitate 
death in a safe way that suicide by other methods cannot (8). 
Conversely, opponents argue that euthanasia and physician-
assisted suicide practices violate the medical code and the 
Hippocratic Oath that all physicians take, result in damage 
to the patient-physician relationship and undermine public 
trust in the health care system (5). They maintain that 
suffering, no matter how unbearable, can be relieved with 
adequate palliative care and/or terminal sedation and warn 
that vulnerable populations including the disadvantaged 
and disabled will be impelled toward premature death (5). 
The “slippery slope” argument is also used by opponents 
who suggest that inevitable and undesired expansion will 
take place once euthanasia and/or physician-assisted suicide 
are legalized and the practices will result in error, abuse 
and infringement on the rights of vulnerable populations 
(35,36). Religious opposition, often based on the principle 
of sanctity of life, is also often encountered (5).
Some of the fiercest debate is focused on assisted dying 
for members of vulnerable groups including those with 
dementia or chronic mental illness, disabilities, the elderly, 
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minors, minorities, those who are socioeconomically 
vulnerable or are just “tired of life” (7,35). Much recent 
heated debate has focused on the complex issue of assisted 
dying requests by those with psychiatric and mental 
disorders, sometimes through the use of an advance 
euthanasia directive (37,38). The controversy often revolves 
around whether psychiatric disorders are an indication 
for assisted dying, the role of mental illness in motivating 
requests for assisted dying, the decisional capacity and 
competency of those making requests and what constitutes 
‘incurable’ or ‘irremediable’ in the context of psychiatric 
conditions (37). The use of euthanasia to alleviate 
unbearable suffering caused by a psychiatric disorder or 
dementia is currently only permitted in the Netherlands, 
Belgium and Luxembourg (38). Since research has shown 
an increase in euthanasia cases among this group since 2008 
there are particular concerns related to establishing mental 
capacity and voluntariness of the request and the increased 
psychological demands on health care professionals involved 
with these cases (38).
The Netherlands and Belgium are the only jurisdictions 
which currently permit the use of assisted dying in infants 
and/or children, but it remains intensely debated in 
international literature (39,40). Although the requirements 
are stringent and assisted dying in children is rare, research 
has shown support among Dutch pediatricians to expand 
eligibility for assisted dying to children younger than 12, 
and some go further to suggest that parents of children 
who are not competent to decide for themselves and 
are suffering unbearably should also be able to request 
euthanasia (40). Many pediatricians in the Netherlands and 
Belgium disagree with strict age limits for euthanasia (40). 
The debate over expanding assisted dying to children has 
been ongoing since the passage of MAiD in Canada (41). 
Autonomy and the capacity to consent are central among 
concerns for opponents (41). Although consideration 
is afforded to minors deemed mature enough to make 
informed decisions for themselves, children are often 
believed to lack the capacity to understand and reason and 
are therefore considered particularly vulnerable, though 
some argue that children should be seen as active agents 
with morally meaningful perspectives which should be 
considered with regard to end-of-life decision making (41). 
Conclusions
While the social and political debate around euthanasia and 
physician-assisted suicide remains fierce and unremitting, 
legislation for assisted dying has expanded significantly in 
Europe, America and Australia over the past 20 years (42). 
Euthanasia and/or physician-assisted suicide practices 
are now legal in 18 jurisdictions (with Western Australia 
coming into effect in 2021), increasing the number of 
people with access to assisted dying to over 200 million (3). 
Considerable variation in terminology and frequency of 
use exists across jurisdictions as well as in the substantive 
and procedural requirements. Many countries are currently 
grappling with issues related to end-of-life care and new 
assisted dying legislation has been proposed in a variety of 
jurisdictions throughout Europe and the US. As access to 
assisted dying increases, the need for additional research 
into the impacts on patients, physicians, health care systems 
and communities is ever more relevant and pressing, as 
is the careful monitoring of adherence to substantive and 
procedural safeguards. Ongoing examination of the impact 
of new and expanded assisted dying legislation on members 
of vulnerable groups, such as those with psychiatric illness 
and minors, will be of particular importance (36,40). With 
demographic, cultural and societal trends worldwide leading 
to increased debate about autonomy and self-determination 
at the end of life, assisted dying will continue to grow as a 
critical public health issue.
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